Do you have an innovative idea to help beat neglected tropical diseases? The Ascend West and Central Africa programme is excited to announce the opening of the second Cycle of the Ascend Learning and Innovation Fund, to accelerate the control and elimination efforts for up to five neglected tropical diseases (NTDs).
The Foundation for Innovative New Diagnostics (FIND), the Global Health Innovative Technology (GHIT) Fund, the Nagasaki University Institute of Tropical Medicine (NUITM) and Leiden University Medical Center (LUMC) and Merck are joining forces to accelerate development and access to a rapid diagnostic test (RDT) for schistosomiasis.
The EIU report examines the burden of schistosomiasis and soil-transmitted helminthiasis and strategies for their control in Ethiopia, Kenya, Rwanda, and Zimbabwe, and estimates the potential economic gains of meeting the WHO’s elimination goals for these diseases in each country.
Did you miss the NNN 2020 Conference? Were you unable to attend a workshop? You can watch the recordings of plenaries, workshops and rapid fire presentations here.
TDR's intersectional gender analysis toolkit aims to strengthen the capacity of researchers working on infectious diseases of poverty by incorporating an intersectional gender approach. Gender, sex and their intersections with other social variables influence everyone's health. Understanding how and why is important for decision-makers and health practitioners to improve the health of their citizens.
The World Health Organization (WHO) published data showing that more than one billion people were treated in 2019 for at least one of the five neglected tropical diseases1 (NTDs) amenable to prevention, control and elimination through large-scale preventive treatment campaigns.
Merck and the NALA Foundation are collabroating with the Federal Ministry of Health of Ethiopia to achieve schistosomiasis elimination.
A series of virtual meetings to unite NTD control programmes, implementing and technical partners, and donors as they consider how NTD programmes might need to change in response to the COVID-19 pandemic.
WHO policy paper discusses how female genital schistosomiasis control can be integrated with HIV and cervical cancer care.
WHO issues interim guidance on the resumption of mass treatment interventions, active case-finding and population-based surveys for NTDs in the context of COVID-19.
Starting with the inaugural webinar on the 17th of June on the new road map, COVID-19 and the road to recovery, the WHO has launched a series of NTD themed webinars.
The WHO have launched a new webpage for schistosomiasis, with info on preventative chemotherapy, mapping, snail control and much more.